Clinical Trials Browser

Phase 4 × Adenocarcinoma × Drug Therapy × Clear all

NCT01665417 2017-02-08

Icotinib as First-line and Maintenance Treatment in EGFR Mutated Patients With Lung Adenocarcinoma

Phase 4 Unknown

Adenocarcinoma

NCT02103257 2015-04-29

Sequential Icotinib Plus Chemotherapy Versus Icotinib Alone as First-line Treatment in Stage IIIB/IV Lung Adenocarcinoma

Phase 4 Unknown

Adenocarcinoma